
SLAS Ignite underscores the Society’s foundational commitment to collaboration, enabling scientists, academic researchers and business development professionals to build relationships as potential strategic partners. Together, SLAS facilitates connections that result in pioneering new research, new products, innovative breakthroughs and commercialization opportunities for all involved.
SLAS Ignite is multi-faceted and includes:

Innovation AveNEW provides start-up or emerging companies in the life sciences and laboratory technology space the opportunity to elevate the promotion of their new company, product or service at the annual SLAS International Conference and Exhibition and/or SLAS Europe Conference and Exhibition.
Companies selected for Innovation AveNEW are given:
Innovation AveNEW companies who opt-in to compete for the SLAS Ignite Award are judged on a combination of key concepts, including their marketing plan, market presence and potential; funding prospects; plan for growth and the existence of a balanced company leadership, among other qualities, for a chance to win $5,000.
Applications are now closed for SLAS2026 and SLAS Europe 2026 program.
To be considered, interested companies must align in some fashion with life sciences research and laboratory technology and while not required, an established relationship with a university, bioscience incubator or research institution is preferable. The company’s products and/or services must be available for sale/distribution within the year of their conference participation.
All applications are reviewed by the Innovation AveNEW Review Panel, who will evaluate applications for technical merit and commercial feasibility as well as other criteria, inclusive of, but not limited to:
SLAS reserves the right to select and deselect any company at any given time. All decisions are final. Companies selected for participation in Innovation AveNEW must agree to and adhere to the rules and regulations for participation.
SLAS is dedicated to advancing life sciences discovery and technology and connecting its users to each other. To fulfill that mission, companies selected to participate in Innovation AveNEW receive at no cost:

The SLAS Ignite Award recognizes the best start-up or emerging company exhibiting within Innovation AveNEW, the specially designated area for start-ups and emerging companies within the SLAS International Conference and Exhibition and SLAS Europe Conference and Exhibition.
Companies selected for Innovation AveNEW, and who opt-in to compete for this prestigious award are judged by an SLAS panel on a combination of key concepts, including their marketing plan, market presence and potential; funding prospect; plan for growth and the existence of balanced company leadership, among other qualities. The winning company takes home a $5,000 cash prize.
2026: XDemics (USA)
2025: InSimili (Italy)
2024: Depixus (France)
2023 Europe: Bionomous SA (Switzerland)
2023: Okomera (France)
2022 Europe: shinephi (an ICFO spin-off, Spain)
2022: BennuBio (USA)
2021 Digital: Artificial, Inc. (USA)
2021 Europe: Hopstem Biotechnology Co., Ltd (China)
2020: Correlia Biosciences (USA)
2019: SEED Biosciences (Switzerland)
View SLAS Ignite Award Guidelines